Evidence map›Paper›PMID 41700787›Full record

ArticleCancer biology & medicine2026

Beyond origin: multimodal AI synthesis to resolve cancers of unknown primary.

Hongru Shen, Xiangchun Li

Abstract read
In one paragraph

Article in Cancer biology & medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hongru ShenKey Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin Medical University, Tianjin 300060, China.
Xiangchun LiKey Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin Medical University, Tianjin 300060, China.ORCID 0000-0002-2230-2152

Funding

China Postdoctoral Science Foundation 2024M762384 to H.S.China Postdoctoral Science Foundation BX20240253National Natural Science Foundation of China 31801117National Natural Science Foundation of China 32270688National Natural Science Foundation of China 32500589 to H.S.National Natural Science Foundation of China 82430107 to X.L.Natural Science Foundation of Tianjin 24JCQNJC01280 to H.S.Tianjin Key Medical Discipline (Specialty) Construction Project TJYXZDXK-3-003A
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41700787
PMCPMC12911432

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.